Patents by Inventor Tore Seternes

Tore Seternes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Oral pharmaceutical dispersion compositions
    Patent number: 10966926
    Abstract: The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic.
    Type: Grant
    Filed: October 19, 2011
    Date of Patent: April 6, 2021
    Assignee: VITUX GROUP AS
    Inventors: Kurt Ingar Draget, Steinar Johan Engelsen, Tore Seternes, Magnus Hattrem, Ingvild Johanne Haug
  • Chewable gelled emulsions
    Patent number: 10668013
    Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.
    Type: Grant
    Filed: June 30, 2017
    Date of Patent: June 2, 2020
    Assignee: VITUX GROUP AS
    Inventors: Tore Seternes, Kurt Ingar Draget, Ingvild Johanne Haug
  • ORAL VETERINARY PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS
    Publication number: 20190269677
    Abstract: This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs.
    Type: Application
    Filed: May 20, 2019
    Publication date: September 5, 2019
    Applicant: VITUX GROUP AS
    Inventors: Kurt Ingar DRAGET, Ingvild Johanne HAUG, Steinar Johan ENGELSEN, Tore SETERNES
  • CHEWABLE GELLED EMULSIONS
    Publication number: 20170296467
    Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.
    Type: Application
    Filed: June 30, 2017
    Publication date: October 19, 2017
    Applicant: VITUX GROUP AS
    Inventors: Tore SETERNES, Kurt Ingar DRAGET, Ingvild Johanne HAUG
  • Chewable gelled emulsions
    Patent number: 9724296
    Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.
    Type: Grant
    Filed: October 15, 2014
    Date of Patent: August 8, 2017
    Assignee: VITUX GROUP AS
    Inventors: Tore Seternes, Kurt Ingar Draget, Ingvild Johanne Haug
  • ORAL VETERINARY PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS
    Publication number: 20170105992
    Abstract: This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs.
    Type: Application
    Filed: December 27, 2016
    Publication date: April 20, 2017
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar DRAGET, Ingvild Johanne HAUG, Steinar Johan ENGELSEN, Tore SETERNES
  • CHEWABLE GELLED EMULSIONS
    Publication number: 20150037438
    Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.
    Type: Application
    Filed: October 15, 2014
    Publication date: February 5, 2015
    Inventors: Tore SETERNES, Kurt Ingar Draget, Ingvild Johanne Haug
  • ORAL PHARMACEUTICAL DISPERSION COMPOSITIONS
    Publication number: 20140163108
    Abstract: The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic.
    Type: Application
    Filed: October 19, 2011
    Publication date: June 12, 2014
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar Draget, Steinar Johan Engelsen, Tore Seternes, Magnus Hattrem, Ingvild Johanne Haug
  • ORAL PHARMACEUTICAL DISPERSION COMPOSITIONS
    Publication number: 20140005179
    Abstract: The invention provides an oral pharmaceutical composition, optionally in dose unit form, comprising a lipophilic drug substance in dispersion in a physiologically tolerable aqueous carrier, preferably an aqueous gel, wherein said drug substance contains a functional electrostatic group having a pKa value of from 2 to 10, characterised in that said aqueous carrier has a pH at least 0.3 below or above said pKa value, said pH being below said pKa where said group is acidic and above said pKa where said group is basic.
    Type: Application
    Filed: April 11, 2011
    Publication date: January 2, 2014
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar Draget, Ingvild Haug, Magnus N. Hattrem, Tore Seternes, Steinar Johan Engelsen
  • ORAL VETERINARY PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS
    Publication number: 20130273025
    Abstract: This invention provides an oral veterinary pharmaceutical or nutraceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion further comprising at least one component selected from taste enhancers, odour enhancers, digestive enzymes and veterinary drugs.
    Type: Application
    Filed: April 11, 2011
    Publication date: October 17, 2013
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes
  • ANTI-ABUSE GELLED PHARMACEUTICAL COMPOSITIONS
    Publication number: 20130274280
    Abstract: This invention provides an oral pharmaceutical composition comprising a physiologically tolerable gelled oil-in-water emulsion containing a drug of abuse.
    Type: Application
    Filed: April 11, 2011
    Publication date: October 17, 2013
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes, Magnus N. Hattrem
  • ANTI-ABUSE PHARMACEUTICAL COMPOSITIONS
    Publication number: 20130273152
    Abstract: This invention provides an oral pharmaceutical composition comprising a physiologically tolerable shell containing a drug of abuse within an oil comprising physiologically tolerable unsaturated fatty acids.
    Type: Application
    Filed: April 11, 2011
    Publication date: October 17, 2013
    Applicant: AYANDA GROUP AS
    Inventors: Kurt Ingar Draget, Ingvild Johanne Haug, Steinar Johan Engelsen, Tore Seternes
  • CHEWABLE GELLED EMULSIONS
    Publication number: 20110268771
    Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a lipophilic drug substance within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion.
    Type: Application
    Filed: October 8, 2009
    Publication date: November 3, 2011
    Applicant: PROBIO ASA
    Inventors: Tore Seternes, Kurt Ingar Draget, Ingvild Johanne Haug
  • CHEWABLE GELLED EMULSIONS
    Publication number: 20110268770
    Abstract: An oral pharmaceutical composition in unit dose form, each unit dose comprising a statin within a unitary carrier body, said body comprising a soft, chewable, gelled oil-in-water emulsion, one or both of the oil phase and the water phase whereof comprises a physiologically tolerable omega-3 acid ester.
    Type: Application
    Filed: October 8, 2009
    Publication date: November 3, 2011
    Applicant: PROBIO ASA
    Inventors: Tore Seternes, Kurt Ingar Draget, Ingvild Johanne Haug